Korea Pharma Co Ltd
KOSDAQ:032300
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Korea Pharma Co Ltd
Accounts Payable
Korea Pharma Co Ltd
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Korea Pharma Co Ltd
KOSDAQ:032300
|
Accounts Payable
₩6.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Accounts Payable
₩175.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Accounts Payable
₩9.3B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Accounts Payable
₩54.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
0%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Accounts Payable
₩4.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
0%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Accounts Payable
₩1.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Korea Pharma Co Ltd
Glance View
KOREA PHARMA Co., Ltd. is engaged in the manufacturing of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2020-08-10. The firm's main products include digestive system solvents, antidepressants, blood circulation agents, antidementia drugs, schizophrenia medicines and others.
See Also
What is Korea Pharma Co Ltd's Accounts Payable?
Accounts Payable
6.7B
KRW
Based on the financial report for Dec 31, 2025, Korea Pharma Co Ltd's Accounts Payable amounts to 6.7B KRW.
What is Korea Pharma Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
-5%
Over the last year, the Accounts Payable growth was -9%. The average annual Accounts Payable growth rates for Korea Pharma Co Ltd have been -2% over the past three years , -5% over the past five years .
